Ironwood Pharmaceuticals Inc (IRWD)

May 12, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 12, 2025

May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025

May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025

May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025

May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025

May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025

May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025

May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025

May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025

May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025

May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025

May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025

May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Yahoo Finance

May 07, 2025

May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025

Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025

Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025

Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025

Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025

Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025

Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025

Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025

Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025

Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025

Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025

Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025

Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025

Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025

Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025

Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025

Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025

Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges - MSN

Apr 15, 2025

Apr 15, 2025

Jefferies Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025

Apr 15, 2025

Wells Fargo Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025

Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges (IRWD:NASDAQ) - Seeking Alpha

Apr 15, 2025

Apr 15, 2025

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Apr 15, 2025

Apr 15, 2025

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7 - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Jefferies Downgrades Ironwood Pharmaceuticals to Hold From Buy, Adjusts Price Target to $0.70 From $8 - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Ironwood crashes down as FDA seeks new phase 3 trial - Pharmaphorum

Apr 15, 2025

Apr 15, 2025

Ironwood (IRWD) Shares Downgraded by Jefferies Following FDA Set - GuruFocus

Apr 15, 2025

Apr 15, 2025

Ironwood's Strategy Shake-Up Raises Eyebrows As Shares Tumble - Finimize

Apr 15, 2025

Apr 15, 2025

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide | IRWD Stock News - GuruFocus

Apr 15, 2025

Apr 14, 2025

Ironwood (IRWD) Plummets After Downgrade and FDA Trial Delay | I - GuruFocus

Apr 14, 2025

Apr 14, 2025

Ironwood To Consider All Options With Apraglutide Setback In SBS - insights.citeline.com

Apr 14, 2025